CLINICAL_TRIALS
trial_result
· 2020-11-19
Clinical Trial Update: Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients [Phase 3]
Summary
Phase 3 long-term safety study of sublingual fentanyl tablets in cancer patients has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED | Results posted: 2020-11-19